Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
154 | Drug Topics | journal | 0.101 Q4 | 8 | 628 | 1008 | 0 | 16 | 820 | 0.01 | 0.00 | |
153 | Journal of Pharmaceutical Finance, Economics and Policy | journal | 0.101 Q4 | 8 | 20 | 20 | 450 | 1 | 19 | 0.05 | 22.50 | |
152 | Modern Drug Discovery | journal | 0.101 Q4 | 9 | 0 | 19 | 0 | 0 | 19 | 0.00 | 0.00 | |
151 | Clinical Research and Regulatory Affairs | journal | 0.102 Q4 | 18 | 15 | 99 | 508 | 5 | 94 | 0.07 | 33.87 | |
150 | Current Protocols in Pharmacology | journal | 0.102 Q4 | 39 | 14 | 85 | 0 | 1 | 85 | 0.00 | 0.00 | |
149 | Journal of Managed Pharmaceutical Care | journal | 0.102 Q4 | 3 | 0 | 35 | 0 | 1 | 34 | 0.00 | 0.00 | |
148 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.102 Q4 | 29 | 0 | 39 | 0 | 3 | 21 | 0.00 | 0.00 | |
147 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.103 Q4 | 31 | 16 | 131 | 0 | 8 | 131 | 0.15 | 0.00 | |
146 | Research Communications in Alcohol and Substances of Abuse | journal | 0.105 Q4 | 5 | 0 | 4 | 0 | 0 | 4 | 0.00 | 0.00 | |
145 | Food and Drug Law Journal | journal | 0.108 Q4 | 23 | 38 | 99 | 1112 | 16 | 96 | 0.11 | 29.26 | |
144 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.113 Q4 | 34 | 7 | 139 | 875 | 28 | 137 | 0.13 | 125.00 | |
143 | Pharmaceutical Chemistry Journal | journal | 0.114 Q4 | 39 | 160 | 548 | 3073 | 12 | 545 | 0.02 | 19.21 | |
142 | Pharmaceutical Outsourcing | journal | 0.117 Q4 | 7 | 42 | 70 | 296 | 2 | 37 | 0.03 | 7.05 | |
141 | Research Communications in Pharmacology and Toxicology | journal | 0.118 Q4 | 8 | 0 | 50 | 0 | 8 | 50 | 0.13 | 0.00 | |
140 | Adverse Drug Reaction Bulletin | journal | 0.119 Q4 | 8 | 6 | 17 | 270 | 2 | 17 | 0.00 | 45.00 | |
139 | Therapeutic Innovation and Regulatory Science | journal | 0.121 Q4 | 51 | 88 | 511 | 1751 | 155 | 499 | 0.29 | 19.90 | |
138 | Journal of Applied Research | journal | 0.124 Q4 | 23 | 76 | 104 | 1861 | 24 | 104 | 0.22 | 24.49 | |
137 | Journal of Research in Pharmaceutical Economics | journal | 0.124 Q4 | 6 | 0 | 30 | 0 | 4 | 24 | 0.00 | 0.00 | |
136 | Journal of Pharmacy Technology | journal | 0.129 Q3 | 16 | 41 | 152 | 940 | 22 | 95 | 0.19 | 22.93 | |
135 | Journal of Infectious Disease Pharmacotherapy | journal | 0.130 Q4 | 6 | 6 | 45 | 119 | 6 | 45 | 0.17 | 19.83 | |
134 | Hospital Pharmacy | journal | 0.142 Q4 | 28 | 139 | 479 | 1835 | 58 | 396 | 0.14 | 13.20 | |
133 | Pharmacopeial Forum (discontinued) | journal | 0.155 Q3 | 20 | 14 | 32 | 307 | 12 | 32 | 0.52 | 21.93 | |
132 | Journal of Natural Toxins | journal | 0.165 Q4 | 28 | 0 | 76 | 0 | 40 | 76 | 0.55 | 0.00 | |
131 | Journal of Medical Marketing | journal | 0.166 Q3 | 20 | 54 | 105 | 705 | 18 | 88 | 0.20 | 13.06 | |
130 | Journal of Herbal Pharmacotherapy | journal | 0.168 Q3 | 33 | 23 | 95 | 489 | 23 | 84 | 0.30 | 21.26 | |
129 | Pharmaceutical Technology Europe | journal | 0.185 Q3 | 19 | 67 | 215 | 408 | 26 | 118 | 0.06 | 6.09 | |
128 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.201 Q3 | 40 | 23 | 128 | 537 | 73 | 128 | 0.04 | 23.35 | |
127 | American Pharmaceutical Review | journal | 0.204 Q3 | 26 | 95 | 142 | 1244 | 68 | 124 | 0.48 | 13.09 | |
126 | National Toxicology Program technical report series | journal | 0.207 | 22 | 8 | 15 | 0 | 5 | 15 | 0.50 | 0.00 | |
125 | Metal-Based Drugs | journal | 0.212 Q3 | 40 | 0 | 60 | 0 | 65 | 60 | 0.50 | 0.00 | |
124 | Proceedings of the Western Pharmacology Society | journal | 0.221 Q3 | 25 | 37 | 197 | 750 | 74 | 197 | 0.33 | 20.27 | |
123 | American Journal of Pharmaceutical Education | journal | 0.222 Q2 | 78 | 118 | 240 | 1724 | 115 | 235 | 0.46 | 14.61 | |
122 | BioPharm International | trade journal | 0.222 Q2 | 32 | 119 | 363 | 576 | 61 | 317 | 0.22 | 4.84 | |
121 | Pharmaceutical Engineering | journal | 0.227 Q2 | 18 | 52 | 135 | 394 | 27 | 135 | 0.20 | 7.58 | |
120 | Dissolution Technologies | journal | 0.244 Q2 | 36 | 24 | 42 | 111 | 11 | 23 | 0.28 | 4.63 | |
119 | Current Therapeutic Research | journal | 0.253 Q3 | 46 | 45 | 249 | 1214 | 154 | 226 | 0.44 | 26.98 | |
118 | Journal of Cannabis Therapeutics | journal | 0.256 Q3 | 18 | 4 | 48 | 323 | 40 | 40 | 0.82 | 80.75 | |
117 | Drug and Chemical Toxicology | journal | 0.257 Q3 | 54 | 30 | 87 | 970 | 62 | 87 | 0.72 | 32.33 | |
116 | AAPS Journal | journal | 0.260 Q2 | 132 | 47 | 219 | 1001 | 171 | 215 | 0.71 | 21.30 | |
115 | Veterinary and Human Toxicology | journal | 0.279 Q3 | 43 | 114 | 315 | 1863 | 189 | 298 | 0.57 | 16.34 | |
114 | IEEE Transactions on Nanobioscience | journal | 0.280 Q2 | 73 | 40 | 63 | 1183 | 76 | 61 | 1.21 | 29.58 | |
113 | In Vitro and Molecular Toxicology: Journal of Basic and Applied Research | journal | 0.287 Q3 | 22 | 0 | 23 | 0 | 25 | 20 | 0.00 | 0.00 | |
112 | Journal of managed care & specialty pharmacy | journal | 0.289 Q2 | 75 | 89 | 101 | 1095 | 47 | 57 | 0.47 | 12.30 | |
111 | Medicinal Chemistry Research | journal | 0.289 Q2 | 59 | 74 | 81 | 1918 | 61 | 79 | 0.46 | 25.92 | |
110 | Pharmaceutical Technology | journal | 0.307 Q2 | 42 | 188 | 363 | 707 | 94 | 286 | 0.21 | 3.76 | |
109 | Drug Development Research | journal | 0.314 Q3 | 67 | 83 | 370 | 4489 | 348 | 364 | 0.83 | 54.08 | |
108 | Artificial Cells, Nanomedicine and Biotechnology | journal | 0.315 Q2 | 86 | 47 | 116 | 1041 | 105 | 114 | 0.96 | 22.15 | |
107 | Pharmaceutical Biotechnology | journal | 0.323 Q2 | 28 | 0 | 16 | 0 | 18 | 16 | 1.13 | 0.00 | |
106 | Medical Letter on Drugs and Therapeutics | journal | 0.351 Q3 | 22 | 65 | 185 | 175 | 131 | 185 | 0.85 | 2.69 | |
105 | International Journal of Toxicology | journal | 0.356 Q3 | 71 | 53 | 217 | 2274 | 179 | 193 | 0.77 | 42.91 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®